Fact Sheet/Brochure

Provides general information about using naloxone to prevent opioid overdose deaths.

Provides a list of data sources to assist agencies, nonprofit groups, organizations, community groups, and coalitions with collecting and assessing data on opioid use.

Provides information about the 2018 Arizona Opioid Epidemic Act for pharmacists and prescribers of opioids, including legal obligations.

Lists the benefits of registering with a prescription drug monitoring program.

Offers tips on how substance use disorder treatment providers can incorporate information related to overdose into different parts of the treatment process, including wait lists, screening/assessment, counseling, induction/orientation, positive drug screens, and discharge.

Provides examples of patient behaviors that may indicate prescription medication abuse or addiction and behaviors that may appear aberrant but are likely to be part of the normal process of stabilizing a patient's pain condition.

Includes when to consider long-term opioid therapy and how to reassess the need for more opioids on a return visit. Provides additional information regarding the evidence about using opioid and nonopioid therapies, evaluating risk of harm or misuse, and assessing pain and function using the PEG scale.

Provides patients with tips for early recovery so they can increase their chances of success.

Provides strategies to build support for expanding the use of medication-assisted treatment (MAT) and resources for securing buy-in.

Equips clinicians with questions to begin discussions with adult patients about alcohol, illicit drug, and mental health problems, as well as co-occurring disorders. Includes resources for patients who need an evaluation after a positive screen.